Furthermore, the activation of Trop-2’s intracellular domain (ICD) can drive tumor cell proliferation; induce epithelial–mesenchymal transition (EMT); and boost tumor cell migration, invasion, and anti-apoptotic capabilities, ultimately hastening tumor progression [14]. Here, TACSTD2 is linked to neoplasm.